Clinical Trial Update: HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

View source ↗

Summary

The HCMR study investigates novel prognostic biomarkers in hypertrophic cardiomyopathy and is currently active but not recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: University of Virginia | Conditions: Hypertrophic Cardiomyopathy | Status: ACTIVE_NOT_RECRUITING